Debates & Insight Sponsored Available on demand: Measuring the cost of the right interve... Available on Demand: Measuring the cost of the right interventions in diabetes.
Debates & Insight Sponsored Available on demand: What's next for patient-centricity? This webinar delved into the challenges that pharma face when looking at their patient-centricity strategy.
News FDA experts lukewarm on AZ's anticoagulant antidote Andexxa AstraZeneca is facing some pushback as it tries to upgrade anticoagulant antidote drug Andexaa to full approval in the US
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends